Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Medpace (MEDP) PT Raised to $38 at Jefferies; Reiterates Hold
November 1, 2017 8:31 AM EDTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $38.00 (from $34.00) while maintaining a Hold rating following the company's 3Q earnings report. 3Q revenue benefited by ~$1.75M from delayed revenue recognition for work completed in 1H17 but for which the client needed to raise funds.... More
